Full View

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

M Peng, X Chu, Y Peng, D Li, Z Zhang, W Wang… - MedComm, 2023 - Wiley Online Library
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …
相关文章

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

M Peng, X Chu, Y Peng, D Li, Z Zhang, W Wang… - Medcomm, 2023 - europepmc.org
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

M Peng, X Chu, Y Peng, D Li, Z Zhang… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

M Peng, X Chu, Y Peng, D Li, Z Zhang, W Wang… - Medcomm, 2023 - sciprofiles.com
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …
[HTML] nih.gov

[HTML][HTML] Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

M Peng, X Chu, Y Peng, D Li, Z Zhang, W Wang… - MedComm, 2023 - ncbi.nlm.nih.gov
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.

M Peng, X Chu, Y Peng, D Li, Z Zhang, W Wang… - Medcomm, 2023 - europepmc.org
Bladder cancer (BC) is one of the most prevalent malignancies in men. Understanding
molecular characteristics via studying signaling pathways has made tremendous …